362 related articles for article (PubMed ID: 17471240)
21. Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment.
Huang C; Ida H; Ito K; Zhang H; Ito Y
Biochem Pharmacol; 2007 Apr; 73(7):990-1000. PubMed ID: 17276407
[TBL] [Abstract][Full Text] [Related]
22. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
23. Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins.
Miyazono K; Maeda S; Imamura T
Oncogene; 2004 May; 23(24):4232-7. PubMed ID: 15156178
[TBL] [Abstract][Full Text] [Related]
24. Runx3 negatively regulates Osterix expression in dental pulp cells.
Zheng L; Iohara K; Ishikawa M; Into T; Takano-Yamamoto T; Matsushita K; Nakashima M
Biochem J; 2007 Jul; 405(1):69-75. PubMed ID: 17352693
[TBL] [Abstract][Full Text] [Related]
25. Lack of RUNX3 regulation in human gastric cancer.
Friedrich MJ; Rad R; Langer R; Voland P; Hoefler H; Schmid RM; Prinz C; Gerhard M
J Pathol; 2006 Oct; 210(2):141-6. PubMed ID: 16917803
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer.
Kitajima Y; Ohtaka K; Mitsuno M; Tanaka M; Sato S; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jan; 19(1):197-202. PubMed ID: 18097595
[TBL] [Abstract][Full Text] [Related]
27. RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers.
Ito K
J Cell Biochem; 2011 May; 112(5):1243-9. PubMed ID: 21465522
[TBL] [Abstract][Full Text] [Related]
28. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.
Carmona-Cuenca I; Roncero C; Sancho P; Caja L; Fausto N; Fernández M; Fabregat I
J Hepatol; 2008 Dec; 49(6):965-76. PubMed ID: 18845355
[TBL] [Abstract][Full Text] [Related]
30. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis.
Sakakura C; Miyagawa K; Fukuda KI; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ida H; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Ito K; Hagiwara A; Ito Y
Oncogene; 2007 Aug; 26(40):5927-38. PubMed ID: 17384682
[TBL] [Abstract][Full Text] [Related]
31. RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells.
Lin FC; Liu YP; Lai CH; Shan YS; Cheng HC; Hsu PI; Lee CH; Lee YC; Wang HY; Wang CH; Cheng JQ; Hsiao M; Lu PJ
Oncogene; 2012 Sep; 31(39):4302-16. PubMed ID: 22231444
[TBL] [Abstract][Full Text] [Related]
32. Causal relationship between the loss of RUNX3 expression and gastric cancer.
Li QL; Ito K; Sakakura C; Fukamachi H; Inoue Ki; Chi XZ; Lee KY; Nomura S; Lee CW; Han SB; Kim HM; Kim WJ; Yamamoto H; Yamashita N; Yano T; Ikeda T; Itohara S; Inazawa J; Abe T; Hagiwara A; Yamagishi H; Ooe A; Kaneda A; Sugimura T; Ushijima T; Bae SC; Ito Y
Cell; 2002 Apr; 109(1):113-24. PubMed ID: 11955451
[TBL] [Abstract][Full Text] [Related]
33. Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas.
Carvalho R; Milne AN; Polak M; Corver WE; Offerhaus GJ; Weterman MA
Oncogene; 2005 Dec; 24(56):8252-8. PubMed ID: 16091737
[TBL] [Abstract][Full Text] [Related]
34. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H
Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504
[TBL] [Abstract][Full Text] [Related]
35. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
Spender LC; Whiteman HJ; Karstegl CE; Farrell PJ
Oncogene; 2005 Mar; 24(11):1873-81. PubMed ID: 15688019
[TBL] [Abstract][Full Text] [Related]
37. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
38. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells.
Yano K; Imaeda T; Niimi T
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G336-43. PubMed ID: 18032479
[TBL] [Abstract][Full Text] [Related]
40. Runx3 expression during mouse tongue and palate development.
Yamamoto H; Ito K; Kawai M; Murakami Y; Bessho K; Ito Y
Anat Rec A Discov Mol Cell Evol Biol; 2006 Jul; 288(7):695-9. PubMed ID: 16761282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]